Ledger.Open graph →
SEC Form D · Amendment · filed July 6, 2023

Incyclix Bio, LLC

Offering
$30.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
RESEARCH TRIANGLE PARK, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Sid N. Subramony · Research Triangle Park, NCDirectorFredric N. Eshelman · Research Triangle Park, NCExec · DirectorPatrick N. Roberts · Research Triangle Park, NCExec · DirectorJohn .. Cogwill · Palo Alto, CADirectorParas Malde · George Town, Grand Cayman, Cayman IslandsExec · DirectorForrest D. Michael · Poole, United KingdomExec · DirectorSharon F. Knight · Cincinnati, OHExec · DirectorChris F. Kane · Cincinnati, OHExec · DirectorJohn Farris · NASHVILLE, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗